61 cases on record
- Cases on record
- 61
- As claimant
- 14
- As respondent
- 47
- Patents held
- Not recorded
- Core tech
- Not recorded
| Case no. | Parties | Role | Court | Filed | Duration | Outcome |
|---|---|---|---|---|---|---|
| 1:25-cv-01168 | Teva Pharmaceutical Industries, Ltd. v. Almaject Inc. | Plaintiff | D. Del. | 18 Sep 2025 | 166 d | Closed |
| 1:25-cv-00928 | Novartis, AG v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 24 Jul 2025 | 124 d | Voluntary dismissal |
| 2:25-cv-03267 | Aurinia Pharmaceuticals, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 25 Apr 2025 | 222 d | Case Consolidated |
| 2:24-cv-11161 | Therapeuticsmd, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 13 Dec 2024 | 10 d | Case Consolidated |
| 2:24-cv-10938 | Axsome Therapeutics, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 5 Dec 2024 | 33 d | Case Consolidated |
| 25-1228 | Teva Pharmaceutical Industries, Ltd. v. Janssen Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 27 Nov 2024 | 223 d | Appeal Dismissed |
| 2:24-cv-09691 | Teva Pharmaceutical Industries, Ltd. v. Cipla Limited | Plaintiff | D.N.J. | 9 Oct 2024 | 117 d | Case Consolidated |
| 2:24-cv-09535 | Axsome Therapeutics, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 30 Sep 2024 | 23 d | Case Consolidated |
| 2:24-cv-08785 | Jazz Pharmaceuticals Ireland Limited v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 27 Aug 2024 | 97 d | Case Consolidated |
| 2:24-cv-07162 | Teva Pharmaceutical Industries, Ltd. v. Cipla Limited | Plaintiff | D.N.J. | 21 Jun 2024 | 273 d | Case Consolidated |
| 24-1936 | Teva Pharmaceutical Industries, Ltd. v. Amneal Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 12 Jun 2024 | 191 d | Unpatentable |
| 2:24-cv-06489 | Axsome Therapeutics, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 28 May 2024 | 259 d | Dismissed without Prejudice |
| 1:24-cv-00627 | Pfizer, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 23 May 2024 | 603 d | Closed |
| 2:24-cv-06104 | Grunenenthal GmbH v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 13 May 2024 | 193 d | Dismissed without Prejudice |
| 2:24-cv-05856 | Teva Pharmaceutical Industries, Ltd. v. Cipla Limited | Plaintiff | D.N.J. | 6 May 2024 | 319 d | Case Consolidated |
| 1:24-cv-00441 | Chiesi Farmaceutici S.P.A. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 8 Apr 2024 | 109 d | Consent Judgment |
| 1:24-cv-00432 | Horizon Therapeutics U.S. Holding LLC v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 5 Apr 2024 | 63 d | Dismissed without Prejudice |
| 1:24-cv-00428 | Novartis, AG v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 4 Apr 2024 | 62 d | Dismissed without Prejudice |
| 1:24-cv-00417 | UroGen Pharma Ltd. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 2 Apr 2024 | 792 d | Dismissed with Prejudice |
| 23-768 | Vanda Pharmaceuticals, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | U.S. Supreme Court | 12 Jan 2024 | 101 d | Petition Dismissed |
| 24-1346 | CORCEPT THERAPEUTICS, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | Fed. Cir. | 11 Jan 2024 | 770 d | Closed |
| 3:24-cv-00197 | Galderma Laboratories v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 11 Jan 2024 | 76 d | Injunction Granted |
| 2:23-cv-23142 | Axsome Therapeutics, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 15 Dec 2023 | 70 d | Case Consolidated |
| 24-1149 | Eli Lilly & Company v. Teva Pharmaceutical Industries, Ltd. | Defendant | Fed. Cir. | 14 Nov 2023 | 664 d | Voluntary dismissal |
| 1:23-cv-01268 | AbbVie, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 7 Nov 2023 | 56 d | Dismissed without Prejudice |
| 24-1094 | Teva Pharmaceutical Industries, Ltd. v. Eli Lilly & Company | Plaintiff | Fed. Cir. | 30 Oct 2023 | 899 d | Reversed and Remanded |
| 2:23-cv-21385 | Impact Biomedicines, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 23 Oct 2023 | 147 d | Consent Judgment |
| 1:23-cv-01080 | Azurity Pharmaceuticals, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 29 Sep 2023 | 228 d | Dismissed with Prejudice |
| 1:23-cv-01008 | Celgene, Corp. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 13 Sep 2023 | 259 d | Consent Judgment |
| 23-2241 | Cipla Limited v. Teva Pharmaceutical Industries, Ltd. | Defendant | Fed. Cir. | 4 Aug 2023 | 557 d | Case Remanded |
| 2:23-cv-03914 | Jazz Pharmaceuticals Research UK Limited v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 21 Jul 2023 | 566 d | Dismissed without Prejudice |
| 1:23-cv-00788 | Teva Pharmaceutical Industries, Ltd. v. BendaRx USA, Corp. | Plaintiff | E.D. Va. | 16 Jun 2023 | 285 d | Case Transferred |
| 1:23-cv-00625 | Array BioPharma, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 8 Jun 2023 | 785 d | Dismissed without Prejudice |
| 1:23-cv-00551 | Bayer AG v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 19 May 2023 | 965 d | Closed |
| 1:23-cv-00374 | AbbVie, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 3 Apr 2023 | 185 d | Case Consolidated |
| 1:23-cv-00362 | AbbVie, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 30 Mar 2023 | 278 d | Dismissed without Prejudice |
| 2:23-cv-01695 | Axsome Therapeutics, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 24 Mar 2023 | 690 d | Dismissed without Prejudice |
| 2:23-cv-01190 | Catalyst Pharmaceuticals, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 1 Mar 2023 | 681 d | Consent Judgment |
| 1:23-cv-00133 | AbbVie, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 3 Feb 2023 | 333 d | Dismissed without Prejudice |
| 2:23-cv-00018 | Jazz Pharmaceuticals Research UK Limited v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 3 Jan 2023 | 765 d | Case Settled |
| 2:22-cv-07528 | Vanda Pharmaceuticals, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 27 Dec 2022 | 45 d | Case Transferred |
| 23-1247 | Vanda Pharmaceuticals, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | Fed. Cir. | 15 Dec 2022 | 146 d | Appeal Dismissed |
| 1:22-cv-01462 | Amicus Therapeutics US, LLC v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 7 Nov 2022 | 717 d | Consent Judgment |
| 22-37 | Teva Pharmaceutical Industries, Ltd. v. GlaxoSmithKline, LLC | Plaintiff | U.S. Supreme Court | 11 Jul 2022 | 308 d | Petition Dismissed |
| 1:22-cv-00513 | Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 22 Apr 2022 | 885 d | Dismissed without Prejudice |
| 1:22-cv-02019 | Evoke Pharma, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 7 Apr 2022 | 298 d | Consent Judgment |
| 1:22-cv-00092 | Neurocrine Biosciences, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 21 Jan 2022 | 432 d | Consent Judgment |
| 1:21-cv-01782 | Novo Nordisk A/S v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 21 Dec 2021 | 643 d | Dismissed without Prejudice |
| 22-1258 | Teva Pharmaceutical Industries, Ltd. v. Janssen Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 14 Dec 2021 | 839 d | Appeal Dismissed in Part |
| 1:21-cv-01043 | Neurocrine Biosciences, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 16 Jul 2021 | 621 d | Case Consolidated |
| 1:21-cv-01001 | Bayer AG v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 7 Jul 2021 | 1646 d | Closed |
| 1:21-cv-00871 | Exelixis, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 17 Jun 2021 | 824 d | Dismissed without Prejudice |
| 1:21-cv-10954 | Teva Pharmaceutical Industries, Ltd. v. Eli Lilly & Company | Plaintiff | D. Mass. | 7 Jun 2021 | 904 d | Case Dismissed |
| 1:21-cv-00695 | Teva Pharmaceutical Industries, Ltd. v. Dr. Reddy | Plaintiff | D. Del. | 13 May 2021 | 692 d | Consent Judgment |
| 2:20-cv-12470 | Alkermes, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 9 Sep 2020 | 1085 d | Case Terminated |
| 2:20-cv-10172 | Teva Pharmaceutical Industries, Ltd. v. Cipla Limited | Plaintiff | D.N.J. | 7 Aug 2020 | 1056 d | Injunction Granted |
| 1:20-cv-00986 | ACADIA Pharmaceuticals, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 24 Jul 2020 | 1383 d | Case Stayed |
| 1:18-cv-12029 | Teva Pharmaceutical Industries, Ltd. v. Eli Lilly & Company | Plaintiff | D. Mass. | 27 Sep 2018 | 1827 d | Judgment on the merits for Defendant |
| 1:18-cv-03632 | CORCEPT THERAPEUTICS, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 15 Mar 2018 | 2115 d | Judgment on the merits for Defendant |
| 2:17-cv-07115 | Indivior, Inc. v. Teva Pharmaceutical Industries, Ltd. | Defendant | D.N.J. | 14 Sep 2017 | 2330 d | Dismissed with Prejudice |
| 1:14-cv-00878 | GlaxoSmithKline v. Teva Pharmaceutical Industries, Ltd. | Defendant | D. Del. | 3 Jul 2014 | 4240 d | Closed |
Source: Patsnap Litigation Data. Cases naming Teva Pharmaceutical Industries, Ltd. in the current snapshot.
Run this in Eureka
Patsnap Eureka
See what Teva Pharmaceutical Industries is protecting
Portfolio, claim scope and where its coverage is thin. Every answer cites the records behind it.
Analyse this portfolio10,000 free credits to start
Teva Pharmaceutical Industries
Map this dispute space
- 01Ranked prior artEvery hit source-linked
- 02Claim-level comparisonAgainst your own product
- 03Legal statusAcross 174 jurisdictions
Disclaimer. This page indexes publicly available court docket data and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Coverage has limits. Records come from a snapshot and may lag live dockets. Sealed filings, amended complaints and post-closure motions may not be reflected, and a case missing from this list is not evidence that it does not exist. Counts on this page describe what the snapshot contains, nothing more.
No characterisation of any party. Appearing on this page means a party is named in a docket record. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, or that any party prevailed.